Bridgeway Capital Management, LLC Equillium, Inc. Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.83 - $2.26 $16,019 - $43,617	19,300 Added 18.17%	125,500 $133,000
Q3 2021 Nov 15, 2021	SELL	$4.84 - $6.91 $169,400 - $241,850	-35,000 Reduced 24.79%	106,200 $724,000
Q2 2021 Aug 16, 2021	BUY	$5.11 - $7.64 $200,312 - $299,488	39,200 Added 38.43%	141,200 $832,000
Q4 2020 Feb 16, 2021	BUY	$3.48 - $6.58 $87,000 - $164,500	25,000 Added 32.47%	102,000 $546,000
Q3 2020 Nov 16, 2020	BUY	$2.78 - $26.5 $5,560 - $53,000	2,000 Added 2.67%	77,000 $444,000
Q2 2020 Aug 14, 2020	BUY	$2.34 - $3.53 $175,500 - $264,750	75,000 New	75,000 $221,000

11.5M

38.1K

Ticker EQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,352,100
Market Cap $47.1M
Description
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.